Related Experiment Videos
[Severe cardiovascular complications relating to Gemeprost therapy]
1Frauenklinik Heilbronn.
Zentralblatt Fur Gynakologie
|July 25, 2000
Summary
Gemeprost vaginal pessaries, used for cervical softening, can cause severe cardiovascular reactions like cardiogenic shock and myocardial infarction due to prostaglandin effects. These rare but serious complications highlight the need for careful patient monitoring during early pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Medicine
- Pharmacology
Background:
- Gemeprost vaginal pessaries are commonly used for cervical softening in early pregnancy.
- Prostaglandins are known to cause various physiological effects, including cardiovascular changes.
- The safety profile of gemeprost is generally considered favorable with minimal complications.
Observation:
- Two cases of severe cardiovascular reactions were observed following gemeprost administration.
- The first patient experienced cardiogenic shock and cerebral stroke.
- The second patient suffered a myocardial infarction.
Findings:
- Both severe reactions were attributed to the prostaglandin effects of gemeprost.
- Cardiovascular events included vasospasm leading to shock and stroke, and coronary spasm causing myocardial infarction.
- These events occurred several hours after the administration of gemeprost vaginal pessaries.
Implications:
- The use of gemeprost may be associated with rare but serious cardiovascular complications.
- Healthcare providers should be vigilant for potential prostaglandin-induced adverse effects.
- Further research into the cardiovascular risks of gemeprost in pregnancy is warranted.